Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 6, 2023

Screening effect and risk factors of lung cancer with low dose CT

Download as PDF

DOI: 10.23977/medsc.2023.040611 | Downloads: 6 | Views: 271

Author(s)

Peirui Chen 1, Zheng Qin 1, Xiaokang Sun 1, Junrong Yang 1, Jing Lv 1, Mingqiang Diao 1

Affiliation(s)

1 Department of Cardiothoracic Surgery, People's Hospital of Deyang City, Deyang, Sichuan, China

Corresponding Author

Peirui Chen

ABSTRACT

To analyze the effect of low-dose CT screening for lung carcinoma and the risk factors associated with lung carcinoma. A total of 568 asymptomatic sufferers who underwent low-dose CT screening for lung carcinoma were regarded, and based on the screening results, they were divided into positive group (n=67) and negative group (n=501), and the risk factors related to lung cancer were analyzed by multivariate Logistic regression. 67 cases (11.79%) were positive for low and medium dose CT screening. Among the 67 positive sufferers, 50 were confirmed as lung carcinoma by pathological biopsy. Multivariate logistic regression analysis showing that age ≥55, low education level and smoking history were associated with lung carcinoma (P < 0.05).So low-dose CT can effectively screen for lung cancer, and age ≥55 years old, low education level and smoking history are independent risk factors for lung cancer. This group could be regarded as the high-risk group for lung carcinoma, so as to better guide the development of low-dose CT screening for lung carcinoma.

KEYWORDS

Low-dose CT; Lung cancer screening; Risk factors; High risk group

CITE THIS PAPER

Peirui Chen, Zheng Qin, Xiaokang Sun, Junrong Yang, Jing Lv, Mingqiang Diao, Screening effect and risk factors of lung cancer with low dose CT. MEDS Clinical Medicine (2023) Vol. 4: 72-75. DOI: http://dx.doi.org/10.23977/medsc.2023.040611.

REFERENCES

[1] Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation [J]. Cochrane Database Syst Rev. 2016; 3: CD00828
[2] National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening [J]. N Engl J Med. 2011; 365:395–409.
[3] De Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced LungCancer Mortality with Volume CT Screening in a Randomized Trial [J]. N Engl J Med. 2020; 382:503–513.
[4] Huang KL, Wang SY, Lu WC, Chang YH, Su J, Lu YT. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis [J]. BMC Pulm Med. 2019; 19:126.
[5] Coureau G, Salmi LR, Etard C, Sancho-Garnier H, Sauvaget C, Mathoulin-Pelissier S. Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials [J]. Eur J Cancer. 2016; 61:146–156.
[6] Yang W, Qian F, Teng J, et al. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening [J]. Lung Cancer. 2018; 117:20–26.
[7] Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial [J]. Lung Cancer. 2008; 59:355–363.
[8] National Lung Screening Trial Research Team, Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer [J]. N Engl J Med. 2013; 368:1980–1991.
[9] Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT [J]. Thorax. 2012; 67: 296–301.
[10] Heleno B, Siersma V, Brodersen J. Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial [J]. JAMA Intern Med. 2018; 178: 1420–1422.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4706
Visits: 205300

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.